DIG
KZIA

Dauntless Investment Group’s Kazia Therapeutics KZIA Stock Holding History

Dauntless Investment Group’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$594K Buy
79,832
+79,831
+7,983,100% +$556K 0.39% 25
2025
Q4 		$7 Sell
1
-118,138
-100% -$1.01M ﹤0.01% 66
2025
Q3 		$852K Buy
118,139
+2,370
+2% +$19.7K 0.53% 34
2025
Q2 		$726K Buy
+115,769
New +$541K 1.26% 14

Other funds holding KZIA

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Dauntless Investment Group's KZIA Position: Q1 2026 in Review

Dauntless Investment Group increased its Kazia Therapeutics (KZIA) stake by 7,983,100% in Q1 2026, buying an estimated $556K and bringing the position to 79,832 shares worth $594K. The position accounts for 0.39% of the portfolio, ranked #25.

Dauntless Investment Group first reported a position in KZIA in Q2 2025 and has held it in 4 quarters since. The position peaked at $852K in Q3 2025. 23 funds tracked by Wall St. Rank hold KZIA as of Q1 2026.

  • Dauntless Investment Group held 79,832 shares of Kazia Therapeutics worth $594K as of Q1 2026.
  • Dauntless Investment Group bought 79,831 Kazia Therapeutics shares in Q1 2026, an estimated $556K.
  • Kazia Therapeutics made up 0.39% of Dauntless Investment Group's portfolio in Q1 2026, its #25 holding.
  • Dauntless Investment Group first reported a position in Kazia Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Dauntless Investment Group's Kazia Therapeutics position peaked at $852K in Q3 2025.
  • 23 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q1 2026.

Based on Dauntless Investment Group's 13F filing for Q1 2026, filed 14 May 2026.